Breaking News Instant updates and real-time market news.

2020-12-01 10:00:39 NNA Navios Acquisition $4.09 / -0.51 (-11.09%) 10:00 12/01/20 12/01 10:00 12/01/20 10:00	Navios Acquisition falls -10.6% Navios Acquisition is down -10.6%, or -49c to $4.10.	01 Dec

2020-12-01 10:00:39

NNA

Navios Acquisition

$4.09 / -0.51 (-11.09%)

10:00

12/01/20

12/01

10:00

12/01/20

10:00

Navios Acquisition falls -10.6%

Navios Acquisition is down -10.6%, or -49c to $4.10.

01
Dec

TODAY'S FREE FLY STORIES

Earnings	Applied Industrial Technologies reports Q2 adjusted EPS 98c, consensus 74c » 06:45 01/28/21 01/28 06:45 01/28/21 06:45 AIT Applied Industrial Technologies $76.83 / -3.09 (-3.87%) Reports Q2 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events AIT Applied Industrial Technologies $76.83 / -3.09 (-3.87%) 01/05/21 Applied Industrial Technologies acquires Gibson Engineering, terms not disclosed 10/07/20 Applied Industrial Technologies acquires Advanced Control Solutions 08/12/20 Applied Industrial Technologies CEO expects 'slow pace near term' AIT Applied Industrial Technologies $76.83 / -3.09 (-3.87%) 11/13/20 KeyBanc Applied Industrial Technologies price target raised to $85 from $75 at KeyBanc 09/01/20 Sidoti Applied Industrial Technologies upgraded to Buy from Neutral at Sidoti 08/13/20 Wells Fargo Applied Industrial Technologies price target raised to $75 from $70 at Wells Fargo 07/02/20 Wells Fargo Applied Industrial Technologies price target raised to $70 from $60 at Wells Fargo AIT Applied Industrial Technologies $76.83 / -3.09 (-3.87%) 10/28/20 Applied Industrial Technologies sees Q2 revenue down 13%-14% y-o-y 10/28/20 Applied Industrial Technologies reports Q1 EPS 89c, consensus 62c 08/12/20 Applied Industrial Technologies sees Q1 revenue down 17%-18% y/y 08/12/20 Applied Industrial Technologies reports Q4 adjusted EPS 80c, consensus 68c 10:00 Today Applied Industrial Technologies - AIT
Earnings	MSCI reports Q4 adjusted EPS $1.96, consensus $1.95 » 06:45 01/28/21 01/28 06:45 01/28/21 06:45 MSCI MSCI $393.74 / -10.02 (-2.48%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events MSCI MSCI $393.74 / -10.02 (-2.48%) 10/27/20 MSCI raises FY20 free cash flow view to $650M-$700M from $540M-$600M 09/25/20 MSCI CFO Linda Huber steps down, Andrew Wiechmann succeeds 07/28/20 MSCI sees FY20 operating expense $790M-$840M MSCI MSCI $393.74 / -10.02 (-2.48%) 12/17/20 Barclays MSCI price target raised to $490 from $360 at Barclays 11/26/20 Atlantic Equities MSCI downgraded to Neutral from Overweight at Atlantic Equities 10/05/20 Oppenheimer MSCI initiated with an Outperform at Oppenheimer 10/05/20 Oppenheimer MSCI initiated with an Outperform at Oppenheimer MSCI MSCI $393.74 / -10.02 (-2.48%) 10/27/20 MSCI reports Q3 adjusted EPS $2.20, consensus $1.80 07/28/20 MSCI reports Q2 adjuted EPS $1.77, consensus $1.67 11:00 Today MSCI - MSCI 02/24/21 MSCI Inc.
Recommendations	Lam Research price target raised to $575 from $530 at Mizuho » 06:45 01/28/21 01/28 06:45 01/28/21 06:45 LRCX Lam Research $515.47 / -37.08 (-6.71%) Mizuho analyst Vijay… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options LRCX Lam Research $515.47 / -37.08 (-6.71%) 12/02/20 Lam Research VP Vahid Vahedi sells almost $1.3M in company shares 11/16/20 Lam Research CFO sells 8.2K shares of common stock 11/05/20 Lam Research announces $5B share repurchase authorization, quarterly dividend 08/27/20 Lam Research raises quarterly dividend 13% to $1.30 per share LRCX Lam Research $515.47 / -37.08 (-6.71%) 01/26/21 Barclays Lam Research price target raised to $600 from $405 at Barclays 01/25/21 B. Riley Securities Lam Research price target raised to $650 from $600 at B. Riley Securities 01/25/21 Credit Suisse Lam Research price target raised to $650 from $450 at Credit Suisse 01/25/21 Deutsche Bank Lam Research price target raised to $575 from $500 at Deutsche Bank LRCX Lam Research $515.47 / -37.08 (-6.71%) 01/27/21 Lam Research sees Q3 EPS $6.55 +/- 40c, consensus $5.72 01/27/21 Lam Research reports Q2 EPS $6.03, consensus $5.72 01/27/21 Notable companies reporting after market close 10/21/20 Lam Research sees Q2 EPS $5.60, +/- 40c, consensus $5.16 LRCX Lam Research $515.47 / -37.08 (-6.71%) 09/28/20 SMIC, China's biggest chipmaker, facing U.S. sanctions, FT reports LRCX Lam Research $515.47 / -37.08 (-6.71%) 12/28/20 Kinnate initiations, Nikola target change among today's top calls on Wall Street 07/29/20 Fly Intel: After-Hours Movers 02/11/21 Technology & Internet Virtual Conference LRCX Lam Research $515.47 / -37.08 (-6.71%) 11/27/20 Early notable gainers among liquid option names on November 27th 10/06/20 Lam Research call volume above normal and directionally bullish 09/24/20 Early notable gainers among liquid option names on September 24th 09/02/20 Lam Research call volume above normal and directionally bullish
Downgrade	Morgan Stanley cuts Equitrans Midstream to Underweight on pipeline risk » 06:44 01/28/21 01/28 06:44 01/28/21 06:44 ETRN Equitrans Midstream $6.48 / -0.3 (-4.42%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events ETRN Equitrans Midstream $6.48 / -0.3 (-4.42%) 01/20/21 Equitrans Midstream falls -10.4% 12/17/20 Equitrans Midstream sees FY21 free cash flow ($150M)-($80M) 12/17/20 Equitrans Midstream sees FY21 CapEx $1.04B-$1.14B 12/17/20 Equitrans Midstream sees FY21 adj. EBITDA $1.035B-$1.105B ETRN Equitrans Midstream $6.48 / -0.3 (-4.42%) 05:31 Today Morgan Stanley Equitrans downgraded to Underweight from Equal Weight at Morgan Stanley 11/18/20 BofA Equitrans Midstream upgraded to Neutral from Underperform at BofA 09/25/20 Morgan Stanley Equitrans Midstream initiated with an Equal Weight at Morgan Stanley 09/09/20 Goldman Sachs Equitrans Midstream initiated with a Neutral at Goldman Sachs ETRN Equitrans Midstream $6.48 / -0.3 (-4.42%) 12/17/20 Equitrans Midstream sees FY21 net income $540M-$610M 11/03/20 Equitrans Midstream reports Q3 adjusted EPS 31c, consensus 32c 08/04/20 Equitrans Midstream reports Q2 adjusted EPS 22c, consensus 37c 02/23/21 Equitrans Midstream - ETRN
Recommendations	Zymeworks price target lowered to $38 from $47 at Barclays » 06:43 01/28/21 01/28 06:43 01/28/21 06:43 ZYME Zymeworks $44.12 / -2.18 (-4.71%) Barclays analyst Gena… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings ZYME Zymeworks $44.12 / -2.18 (-4.71%) 01/27/21 Zymeworks begins patient enrollment into expansion cohort of ph1 ZW49 trial 01/15/21 Zymeworks announces new, updated zanidatamab data at ASCO 12/01/20 Zymeworks expands zanidatamab trial in HER2 in amplified biliary tract cancer 11/30/20 Zymeworks gets FDA breakthrough therapy designation for zanidatamab ZYME Zymeworks $44.12 / -2.18 (-4.71%) 01/25/21 Citi Zymeworks downgraded to Neutral ahead of initial ZW49 data at Citi 01/25/21 Citi Zymeworks downgraded to Neutral from Buy at Citi 01/12/21 SVB Leerink Zymeworks price target raised to $66 from $45 at SVB Leerink 01/12/21 Wells Fargo Zymeworks price target raised to $71 from $58 at Wells Fargo ZYME Zymeworks $44.12 / -2.18 (-4.71%) 11/03/20 Zymeworks reports Q3 EPS ($1.43), consensus (67c) 08/05/20 Zymeworks reports Q2 EPS (77c), consensus (67c)

Recommendations	j2 Global price target raised to $120 from $98 at JMP Securities » 06:43 01/28/21 01/28 06:43 01/28/21 06:43 JCOM j2 Global $106.12 / +3.68 (+3.59%) JMP Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events JCOM j2 Global $106.12 / +3.68 (+3.59%) 12/16/20 j2 Global CFO sells 10.3K shares of common stock 10/15/20 j2 Global partners with NAACP on $6M media program 09/29/20 j2 Global to acquire RetailMeNot for $420M from Vericast 08/10/20 j2 Global up 14% after Q2 earnings beat at $68.50 per share JCOM j2 Global $106.12 / +3.68 (+3.59%) 12/16/20 JPMorgan j2 Global price target raised to $120 from $105 at JPMorgan 11/04/20 Baird j2 Global price target raised to $90 from $85 at Baird 11/04/20 Susquehanna j2 Global shares remain severely undervalued, says Susquehanna 11/04/20 Citi j2 Global price target raised to $100 from $90 at Citi JCOM j2 Global $106.12 / +3.68 (+3.59%) 11/02/20 j2 Global raises FY20 adjusted EPS view to $7.85-$8.00 from $7.17-$7.41 11/02/20 j2 Global reports Q3 adjusted EPS $2.02, consensus $1.77 08/10/20 j2 Global sees FY20 adjusted EPS $7.17-$7.41, consensus $6.87 08/10/20 j2 Global reports Q2 adjusted EPS $1.71, consensus $1.45 JCOM j2 Global $106.12 / +3.68 (+3.59%) 11/02/20 Fly Intel: After-Hours Movers 08/11/20 Fly Intel: Wall Street's top stories for Tuesday 08/11/20 Fly Intel: Wall Street's top stories at midday 08/10/20 Fly Intel: After-Hours Movers 02/12/21 j2 Global - JCOM
Earnings	Brunswick raises FY21 adjusted EPS view to $6.00-$6.40 from $5.75-$6.25 » 06:42 01/28/21 01/28 06:42 01/28/21 06:42 BC Brunswick $91.34 / -1.26 (-1.36%) Consensus for FY21 EPS is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events BC Brunswick $91.34 / -1.26 (-1.36%) 01/25/21 Brunswick expands boat production capacity to meet demand 01/19/21 Brunswick expands access to on-water training, launches BoatClass 01/06/21 Brunswick's Mercury Marine division installs solar array at headquarters 11/12/20 Brunswick launches consumer advisory board BC Brunswick $91.34 / -1.26 (-1.36%) 01/27/21 Truist Brunswick price target raised to $105 from $95 at Truist 01/12/21 B. Riley Securities Brunswick price target raised to $102 from $93 at B. Riley Securities 11/20/20 JPMorgan Brunswick price target raised to $85 from $79 at JPMorgan 10/20/20 JPMorgan Brunswick upgraded to Overweight on surging boat sales at JPMorgan BC Brunswick $91.34 / -1.26 (-1.36%) 06:39 Today Brunswick reports Q4 adjusted EPS $1.32, consensus $1.02 01/27/21 Notable companies reporting before tomorrow's open 01/27/21 Notable companies reporting before tomorrow's open 10/29/20 Brunswick sees FY21 adjusted EPS $5.75-$6.25, consensus $5.31 11:00 Today Brunswick - BC 03/10/21 Brunswick
Recommendations	Blackstone price target raised to $75 from $70 at Barclays » 06:42 01/28/21 01/28 06:42 01/28/21 06:42 BX Blackstone $65.25 / +0.13 (+0.20%) Barclays analyst Jeremy… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options BX Blackstone $65.25 / +0.13 (+0.20%) 01/26/21 Allstate to sell Allstate Life Insurance Co. to Blackstone entities for $2.8B 01/26/21 Allstate to sell Allstate Life Insurance Co. to Blackstone entities for $2.8B 01/24/21 Fly Intel: Top five weekend stock stories 01/06/21 UnitedHealth's Optum to acquire Change Healthcare for $25.75 per share in cash BX Blackstone $65.25 / +0.13 (+0.20%) 01/27/21 Evercore ISI Allstate unit sale transaction 'a clear positive,' says Evercore ISI 01/14/21 Fly Intel: Top five analyst initiations 01/14/21 Piper Sandler Blackstone initiated with an Overweight at Piper Sandler 10/29/20 Oppenheimer Blackstone upgraded to Outperform at Oppenheimer BX Blackstone $65.25 / +0.13 (+0.20%) 01/27/21 Blackstone reports Q4 distributable EPS $1.13, consensus 89c 01/26/21 Notable companies reporting before tomorrow's open 01/26/21 Notable companies reporting before tomorrow's open 10/29/20 Blackstone reported Q3 distributable EPS 63c, consensus 57c (yesterday) BX Blackstone $65.25 / +0.13 (+0.20%) 01/24/21 Foley-backed SPAC nears $7.3B deal with Blackstone's Alight, Reuters reports 01/12/21 Blackstone's Aadhar intends to file for IPO in India, Bloomberg says 01/07/21 Carlyle working with banks on rival bid for Signature Aviation, Sky News says 01/05/21 Oatly planning 2021 initial public offering, CNBC reports BX Blackstone $65.25 / +0.13 (+0.20%) 01/03/21 Opening Day: Six IPOs to watch in 2021 11/20/20 Fly Intel: Wall Street's top stories at midday 09/10/20 Fly Intel: Wall Street's top stories for Thursday 09/10/20 Fly Intel: Wall Street's top stories at midday BX Blackstone $65.25 / +0.13 (+0.20%) 12/15/20 Largest borrow rate increases among liquid names 12/09/20 Blackstone call volume above normal and directionally bullish 11/18/20 Blackstone trader unwinds massive election hedge after nearly a month 10/21/20 Unusual put flow in option market yesterday
Hot Stocks	Broadridge begins development to be an approved SFT submitter » 06:42 01/28/21 01/28 06:42 01/28/21 06:42 BR Broadridge $143.68 / -8.16 (-5.37%) Broadridge Financial… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events BR Broadridge $143.68 / -8.16 (-5.37%) 12/08/20 Broadridge selected by BEC for updated Shareholder Rights Directive 11/09/20 Broadridge names Edmund Reese as CFO, effective November 30 11/02/20 LiquidX announces multi-year investment from Broadridge 10/30/20 Broadridge narrows FY21 adjusted EPS view to 6%-10% from 4%-10% BR Broadridge $143.68 / -8.16 (-5.37%) 12/18/20 Truist Broadridge initiated with a Buy at Truist 12/18/20 Truist Broadridge initiated with a Buy at Truist 08/17/20 JPMorgan Broadridge price target raised to $152 from $142 at JPMorgan 08/12/20 Fly Intel: Top five analyst downgrades BR Broadridge $143.68 / -8.16 (-5.37%) 12/10/20 Broadridge backs FY21 adjusted EPS growth of 6%-10%, consensus $5.50 12/10/20 Broadridge targets adjusted EPS growth FY20-FY23 of 8%-12% 10/30/20 Broadridge reports Q1 adjusted EPS 98c, consensus 63c 08/11/20 Broadridge sees FY21 adjusted EPS growth 4%10%, consensus $5.44 02/02/21 Broadridge - BR
Earnings	Eagle Materials reports Q3 adjusted EPS $1.94, consensus $1.74 » 06:42 01/28/21 01/28 06:42 01/28/21 06:42 EXP Eagle Materials $108.24 / -3.09 (-2.78%) Reports Q3 revenue $405M,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research Earnings Events EXP Eagle Materials $108.24 / -3.09 (-2.78%) 01/22/21 JPMorgan Eagle Materials price target raised to $130 from $115 at JPMorgan 01/06/21 Loop Capital Loop raises Eagle Materials price target to $125, names 'best idea' for 2021 11/19/20 Goldman Sachs Eagle Materials upgraded to Buy from Neutral at Goldman Sachs 11/19/20 Loop Capital Eagle Materials upgraded to Buy from Hold at Loop Capital EXP Eagle Materials $108.24 / -3.09 (-2.78%) 10/29/20 Eagle Materials reports Q2 cont-op EPS $2.16 with items, consensus $1.85 07/30/20 Eagle Materials reports Q1 adjusted EPS $1.57, consensus $1.12 08:30 Today Eagle Materials - EXP

Recommendations	ServiceNow price target raised to $655 from $650 at Barclays » 06:41 01/28/21 01/28 06:41 01/28/21 06:41 NOW ServiceNow $518.15 / -14.66 (-2.75%) Barclays analyst Raimo… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events NOW ServiceNow $518.15 / -14.66 (-2.75%) 01/27/21 ServiceNow jumps about 5% to $541 after Q4 earnings beat 01/27/21 ServiceNow reports Q4 subscription billings $1.83B, up 41% from last year 01/27/21 NHS Scotland selects ServiceNow to aid 5.5M citizen vaccinations 01/13/21 SurveyMonkey announces integration with ServiceNow NOW ServiceNow $518.15 / -14.66 (-2.75%) 04:58 Today Oppenheimer ServiceNow price target raised to $610 from $600 at Oppenheimer 01/22/21 OTR Global ServiceNow upgraded to Positive from Mixed at OTR Global 01/22/21 Cowen ServiceNow price target raised to $600 from $575 at Cowen 01/21/21 Goldman Sachs ServiceNow assumed with a Buy at Goldman Sachs NOW ServiceNow $518.15 / -14.66 (-2.75%) 01/27/21 ServiceNow reports Q4 adjusted EPS $1.17, consensus $1.05 01/27/21 Notable companies reporting after market close 10/28/20 ServiceNow raises 2020 subscription revenue outlook to $4.25B-$4.26B 10/28/20 ServiceNow sees Q4 subscription revenue up 27% to $1.14B-$1.15B NOW ServiceNow $518.15 / -14.66 (-2.75%) 01/27/21 Fly Intel: After-Hours Movers 01/14/21 Shopify, Intel upgrades among today's top calls on Wall Street 12/16/20 Microsoft reinstatement, Spotify downgrade among top calls on Wall Street 11/24/20 Target upgrade, Microsoft initiation among today's top calls on Wall Street 08:00 Today Technology
Recommendations	PTC price target raised to $145 from $142 at Barclays » 06:41 01/28/21 01/28 06:41 01/28/21 06:41 PTC PTC $121.12 / -8.44 (-6.51%) Barclays analyst Saket… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events PTC PTC $121.12 / -8.44 (-6.51%) 12/14/20 PTC to acquire Arena Solutions for $715M in cash 11/10/20 PTC names Troy Richardson as COO 10/28/20 PTC, Rockwell Automation extend strategic alliance 09/08/20 Teradata promotes Hillary Ashton to chief product officer PTC PTC $121.12 / -8.44 (-6.51%) 06:10 Today RBC Capital PTC upgraded to Outperform from Sector Perform at RBC Capital 05:29 Today RBC Capital PTC upgraded to Outperform from Sector Perform at RBC Capital 01/21/21 Barclays PTC price target raised to $142 from $130 at Barclays 01/12/21 Mizuho PTC price target raised to $150 from $130 at Mizuho PTC PTC $121.12 / -8.44 (-6.51%) 01/27/21 PTC reports Q1 EPS 97c, consensus 65c 01/27/21 PTC raises FY21 non-GAAP EPS view to $2.65-$2.85 from $3.05-$3.25 12/16/20 PTC Q1 ARR tracking to midpoint of $1.28B-$1.32B guidance range 10/28/20 PTC sees FY21 non-GAAP EPS $2.65-$2.85, consensus $2.83 PTC PTC $121.12 / -8.44 (-6.51%) 01/27/21 Fly Intel: After-Hours Movers 12/09/20 JPMorgan downgrades Zoom, upgrades Autodesk in software ratings shakeup 07/29/20 Fly Intel: After-Hours Movers 02/10/21 PTC Inc
Hot Stocks	Darling Ingredients, Valero joint venture receives approval for Texas facility » 06:41 01/28/21 01/28 06:41 01/28/21 06:41 DAR Darling Ingredients $60.62 / -5.3 (-8.04%) , VLO Valero $58.76 / +0.61 (+1.05%) Darling (DAR) and Valero… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options DAR VLO DAR Darling Ingredients $60.62 / -5.3 (-8.04%) 10/27/20 Darling Ingredients' joint venture receives air permit from TCEQ VLO Valero $58.76 / +0.61 (+1.05%) 06:27 Today Valero sees FY21 capital investments $2B 06:26 Today Valero declares quarterly dividend of 98c per share 12/04/20 Valero CEO sells 39.2K shares of common stock 10/22/20 Valero sees 2020, 2021 capital investments $2B per year DAR VLO DAR Darling Ingredients $60.62 / -5.3 (-8.04%) 01/27/21 JPMorgan Darling Ingredients price target raised to $69 from $48 at JPMorgan 11/05/20 BMO Capital Darling Ingredients price target raised to $46 from $33 at BMO Capital 10/22/20 Roth Capital Darling Ingredients price target raised to $84 from $38 at Roth Capital 10/21/20 Wolfe Research Darling Ingredients initiated with an Outperform at Wolfe Research VLO Valero $58.76 / +0.61 (+1.05%) 01/26/21 Fly Intel: Top five analyst initiations 01/26/21 Valero started with a Neutral at UBS on 'valuation near historic levels' 01/26/21 UBS Valero initiated with a Neutral at UBS 12/11/20 Morgan Stanley Morgan Stanley upgrades two, downgrades one in refining rating rebalance DAR VLO DAR Darling Ingredients $60.62 / -5.3 (-8.04%) 11/03/20 Darling Ingredients reports Q3 GAAP EPS 61c, consensus 44c 08/05/20 Darling Ingredients reports Q2 EPS 39c, consensus 31c VLO Valero $58.76 / +0.61 (+1.05%) 06:25 Today Valero reports Q4 adjusted EPS ($1.06), consensus ($1.42) 10/22/20 Valero reports Q3 adjusted EPS ($1.16), consensus ($1.37) 07/30/20 Valero reports Q2 adjusted EPS ($1.25), consensus ($1.41) 07/29/20 Notable companies reporting before tomorrow's open VLO VLO Valero $58.76 / +0.61 (+1.05%) 12/30/20 Dallas Fed survey sees about half of U.S. energy co's expect '21 capex boost 09/16/20 White House mulls at least $300M in aid to U.S. oil refiners, Reuters says VLO VLO Valero $58.76 / +0.61 (+1.05%) 09/19/20 Week in review: How Trump's policies moved stocks 03/15/21 33rd Annual Roth Virtual Conference 03/18/21 Waste & Environmental Services Virtual Symposium 10:00 Today Valero - VLO VLO VLO Valero $58.76 / +0.61 (+1.05%) 12/02/20 Valero call volume above normal and directionally bullish 11/16/20 Unusually active option classes on open November 16th 10/26/20 Unusually active option classes on open October 26th 10/23/20 Early notable gainers among liquid option names on October 23rd
Recommendations	Navient price target raised to $16 from $13 at Barclays » 06:40 01/28/21 01/28 06:40 01/28/21 06:40 NAVI Navient $11.16 / -0.71 (-5.98%) Barclays analyst Mark… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events NAVI Navient $11.16 / -0.71 (-5.98%) 01/27/21 Navient says strong performance will continue into 2021 01/15/21 California AG sues Education Department over for-profit collegerule easing 11/16/20 Omega takes Alphabet Class A stake, exits position in JPMorgan 10/21/20 Navient sees FY20 core ROE in the high 20s vs. previous high teens to low 20s NAVI Navient $11.16 / -0.71 (-5.98%) 01/19/21 JPMorgan Navient downgraded to Neutral with $12.50 target at JPMorgan 01/19/21 JPMorgan Navient downgraded to Neutral from Overweight at JPMorgan 10/22/20 Fly Intel: Top five analyst upgrades 10/22/20 Wedbush Navient upgraded to Outperform at Wedbush NAVI Navient $11.16 / -0.71 (-5.98%) 01/27/21 Navient sees FY21 EPS $3.10-$3.25, consensus $3.07 01/26/21 Navient reports Q4 adjusted EPS 97c, consensus 83c 01/26/21 Notable companies reporting after market close 10/21/20 Navient increases FY20 core EPS view to $3.25-$3.28 from $2.95-$3.00 NAVI Navient $11.16 / -0.71 (-5.98%) 01/26/21 Fly Intel: After-Hours Movers 10/21/20 Fly Intel: Pre-market Movers 10/20/20 Fly Intel: After-Hours Movers 02/24/21 22nd Annual Virtual Financial Services Forum
Hot Stocks	Jackson to fully separate from Prudential through proposed spin-off in Q2 » 06:40 01/28/21 01/28 06:40 01/28/21 06:40 PRU Prudential $79.19 / -2.02 (-2.49%) , MET MetLife $48.41 / -1.69 (-3.37%) Prudential (PRU), the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options PRU MET PRU Prudential $79.19 / -2.02 (-2.49%) 01/14/21 Genesis Healthcare selects Prudential to oversee $1.1B in retirement assets 01/14/21 Genesis Healthcare selects Prudential to oversee $1.1B in retirement assets 09/17/20 Prudential appoints Susan Johnson as chief marketing officer 09/14/20 Prudential sees any COVID-19 vaccine being distributed slowly MET MetLife $48.41 / -1.69 (-3.37%) 12/11/20 MetLife to sell auto & home business to Zurich Insurance unit for $3.94B in cash 12/11/20 MetLife announces new $3B share repurchase program 11/23/20 SmileDirectClub partners with MetLife 11/02/20 MetLife names Pawan Verma as new CIO PRU MET PRU Prudential $79.19 / -2.02 (-2.49%) 12/08/20 Citi Prudential upgraded to Neutral from Sell at Citi 12/04/20 Goldman Sachs Prudential initiated with a Buy at Goldman Sachs 11/17/20 Barclays Prudential initiated with an Equal Weight at Barclays 05/06/20 Piper Sandler Prudential downgraded to Neutral at Piper Sandler following Q1 results MET MetLife $48.41 / -1.69 (-3.37%) 01/06/21 Fly Intel: Top five analyst upgrades 01/06/21 Piper Sandler MetLife upgraded to Overweight from Neutral at Piper Sandler 12/08/20 Citi MetLife upgraded to Buy from Neutral at Citi 12/04/20 Goldman Sachs MetLife initiated with a Neutral at Goldman Sachs PRU MET PRU Prudential $79.19 / -2.02 (-2.49%) 11/03/20 Prudential reports Q3 adjusted ops EPS $3.21, consensus $2.72 11/03/20 Notable companies reporting after market close 08/04/20 Prudential reports Q2 adjusted EPS $1.85, consensus $1.71 08/04/20 Notable companies reporting after market close MET MetLife $48.41 / -1.69 (-3.37%) 11/04/20 MetLife reports Q3 adjusted EPS $1.95, consensus $1.61 11/04/20 Notable companies reporting after market close 08/05/20 MetLife reports Q2 adjusted EPS $1.38, consensus 90c 08/05/20 Notable companies reporting after market close MET MET MetLife $48.41 / -1.69 (-3.37%) 11/20/20 MetLife near $4B deal to sell unit to Zurich Insurance, Reuters reports 11/20/20 Zurich Insurance in talks to buy MetLife unit for close to $4B, Reuters says PRU MET PRU Prudential $79.19 / -2.02 (-2.49%) 11/03/20 Fly Intel: After-Hours Movers MET MetLife $48.41 / -1.69 (-3.37%) 08/05/20 Fly Intel: After-Hours Movers 02/04/21 MetLife - MET 02/05/21 Prudential - PRU MET MET MetLife $48.41 / -1.69 (-3.37%) 01/05/21 MetLife call volume above normal and directionally bullish 09/08/20 MetLife put volume heavy and directionally bearish 09/02/20 MetLife put volume heavy and directionally bearish 08/11/20 MetLife call volume above normal and directionally bullish

Initiation	SOC Telemed initiated with an Outperform at RBC Capital » 06:39 01/28/21 01/28 06:39 01/28/21 06:39 TLMD SOC Telemed / + RBC Capital analyst Sean… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Options TLMD SOC Telemed / + 01/12/21 SOC Telemed appoints new Chief Human Resources and new Chief Customer officers 10/30/20 SOC Telemed closes business combination with Healthcare Merger Corp. TLMD SOC Telemed / + 01/15/21 Benchmark SOC Telemed initiated with a Buy at Benchmark 01/15/21 BTIG SOC Telemed downgraded to Neutral from Buy at BTIG 01/15/21 BTIG SOC Telemed downgraded to Neutral from Buy at BTIG 01/08/21 Baird Vocera downgraded to Neutral on valuation at Baird TLMD SOC Telemed / + 11/02/20 Nine new option listings and four option delistings on November 2nd
Hot Stocks	Eli Lilly to acquire exclusive rights for AK1780 from Asahi Kasei Pharm » 06:39 01/28/21 01/28 06:39 01/28/21 06:39 LLY Eli Lilly $207.73 / -5.17 (-2.43%) Eli Lilly and Company and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options LLY Eli Lilly $207.73 / -5.17 (-2.43%) 01/27/21 Eli Lilly awarded $625M Army contract modification for 500,000 LY-CoV555 doses 01/27/21 AbCellera-found antibody, bamlanivimab, to be developed with VIR-7831 for Covid 01/27/21 Eli Lilly, Vir and GlaxoSmithKline announce collaboration 01/27/21 Eli Lilly, Vir, GlaxoSmithKline: First patient dosed in BLAZE-4 trail LLY Eli Lilly $207.73 / -5.17 (-2.43%) 01/27/21 H.C. Wainwright Vir collaboration gives H.C. Wainwright more confidence in COVID-19 program 01/26/21 Berenberg Eli Lilly data 'incrementally positive' for AbCellera, says Berenberg 01/20/21 Citi Citi opens 'positive Catalyst Watch' on Eli Lilly into Alzheimer's data 01/19/21 Roth Capital Merus price target raised to $32 from $19 at Roth Capital LLY Eli Lilly $207.73 / -5.17 (-2.43%) 12/15/20 Eli Lilly sees FY21 EPS $7.75-$8.40, consensus $8.07 12/15/20 Eli Lilly raises FY20 EPS view to $7.45-$7.65 from $7.20-$7.40, consensus $7.32 12/02/20 Eli Lilly says updated purchase of LY-CoV555 to boost FY20 EPS view by 25c 10/27/20 Eli Lilly backs FY20 adj. EPS view $7.20-$7.40, consensus $7.28 LLY Eli Lilly $207.73 / -5.17 (-2.43%) 12/30/20 Fresenius to administer Lilly, Regeneron COVID antibody drugs, Reuters says 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says 11/20/20 Trump to release new rules aimed at lowering drug prices, WSJ reports LLY Eli Lilly $207.73 / -5.17 (-2.43%) 01/27/21 Fly Intel: Wall Street's top stories for Wednesday 01/27/21 Fly Intel: Wall Street's top stories at midday 01/21/21 Fly Intel: Wall Street's top stories for Thursday 01/21/21 Fly Intel: Wall Street's top stories at midday 01/26/21 Pharmacovigilance & Risk Management Strategies Virtual Conference 03/01/21 41st Annual Healthcare Virtual Conference 01/29/21 Eli Lilly - LLY LLY Eli Lilly $207.73 / -5.17 (-2.43%) 01/15/21 Eli Lilly call volume above normal and directionally bullish 01/13/21 Early notable gainers among liquid option names on January 13th 01/11/21 Early notable gainers among liquid option names on January 11th 12/09/20 Early notable gainers among liquid option names on December 9th
Earnings	Brunswick reports Q4 adjusted EPS $1.32, consensus $1.02 » 06:39 01/28/21 01/28 06:39 01/28/21 06:39 BC Brunswick $91.34 / -1.26 (-1.36%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events BC Brunswick $91.34 / -1.26 (-1.36%) 01/25/21 Brunswick expands boat production capacity to meet demand 01/19/21 Brunswick expands access to on-water training, launches BoatClass 01/06/21 Brunswick's Mercury Marine division installs solar array at headquarters 11/12/20 Brunswick launches consumer advisory board BC Brunswick $91.34 / -1.26 (-1.36%) 01/27/21 Truist Brunswick price target raised to $105 from $95 at Truist 01/12/21 B. Riley Securities Brunswick price target raised to $102 from $93 at B. Riley Securities 11/20/20 JPMorgan Brunswick price target raised to $85 from $79 at JPMorgan 10/20/20 JPMorgan Brunswick upgraded to Overweight on surging boat sales at JPMorgan BC Brunswick $91.34 / -1.26 (-1.36%) 01/27/21 Notable companies reporting before tomorrow's open 01/27/21 Notable companies reporting before tomorrow's open 10/29/20 Brunswick sees FY21 adjusted EPS $5.75-$6.25, consensus $5.31 10/29/20 Brunswick sees Q4 revenue up in low-to-mid teens, consensus $1.02B 11:00 Today Brunswick - BC 03/10/21 Brunswick
Recommendations	Duke Energy price target raised to $108 from $102 at Barclays » 06:38 01/28/21 01/28 06:38 01/28/21 06:38 DUK Duke Energy / + Barclays analyst Eric… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options DUK Duke Energy / + 01/25/21 Duke Energy announces milestone settlement on costs related to coal ash 01/11/21 Albemarle names Melissa Anderson as Chief Human Resources Officer 01/07/21 Duke Energy Renewables acquires solar project in Texas from Canadian Solar 12/11/20 Duke Energy responds to NC Supreme Court ruling on coal ash costs DUK Duke Energy / + 01/14/21 Goldman Sachs Duke Energy downgraded to Neutral from Buy at Goldman Sachs 11/24/20 Fly Intel: Top five analyst initiations 11/24/20 BMO Capital Duke Energy initiated with an Outperform at BMO Capital 11/18/20 Barclays Duke Energy price target raised to $102 from $87 at Barclays DUK Duke Energy / + 11/05/20 Duke Energy narrows FY20 adj. EPS view to $5.05-$5.20 from $5.05-$5.45 11/05/20 Duke Energy reports Q3 adjusted EPS $1.87, consensus $1.79 08/10/20 Duke Energy backs FY20 adjusted EPS view $5.05-$5.45, consensus $5.07 08/10/20 Duke Energy reports Q2 EPS $1.08, consensus $1.03 DUK Duke Energy / + 10/23/20 NextEra appears to have 'moved on' from Duke Energy pursuit, CNBC's Faber says 10/08/20 Duke Energy CEO calls NextEra takeover offer a 'rumor,' Bloomberg says 10/02/20 Duke Energy rebuffed NextEra, left door open for further talks, FT reports 09/30/20 Duke Energy rebuffed NextEra Energy takeover approach, WSJ reports DUK Duke Energy / + 09/30/20 Fly Intel: Wall Street's top stories for Wednesday 09/30/20 Fly Intel: Wall Street's top stories at midday 09/30/20 Fly Intel: Pre-market Movers 02/11/21 Duke Energy - DUK DUK Duke Energy / + 11/12/20 Duke Energy put volume heavy and directionally bearish 09/30/20 Early notable gainers among liquid option names on September 30th 09/09/20 Early notable gainers among liquid option names on September 9th
Recommendations	General Electric price target raised to $13 from $12 at Barclays » 06:38 01/28/21 01/28 06:38 01/28/21 06:38 GE General Electric / + Barclays analyst Julian… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GE General Electric / + 01/26/21 General Electric: Aviation to see continued challenges in 2021 01/26/21 GE: 2020 orders down 17%, with 95% of the pressure aviation-related 01/26/21 General Electric CEO sees 'considerable improvement' from mid-2020 01/26/21 General Electric CEO: 'It's hard to think of a tougher year' than 2020 GE General Electric / + 01/27/21 Morgan Stanley General Electric price target raised to $13 from $12 at Morgan Stanley 01/27/21 Citi General Electric developing track record of delivering, says Citi 01/07/21 JPMorgan GE shares 'de-coupled from long term fundamentals,' says JPMorgan 12/16/20 DZ Bank General Electric upgraded to Hold from Sell at DZ Bank GE General Electric / + 01/26/21 General Electric sees FY21 adjusted EPS 15c-25c, consensus 38c 01/26/21 General Electric reports Q4 adjusted EPS 8c, consensus 9c 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open GE General Electric / + 01/14/21 GE says Siemens stole trade secrets in bid to rig contracts , Reuters reports 01/11/21 GE to pause donations to lawmakers who voted against Biden win, Bloomberg says 01/09/21 Some century-old stocks still deliver, Barron's says 01/05/21 GE board won't attempt to claw back former CEO's pay, WSJ reports GE General Electric / + 01/27/21 Nokia soars but company 'not aware' of apparent reason for trading activity 01/26/21 Fly Intel: Wall Street's top stories for Tuesday 01/26/21 Fly Intel: Pre-market Movers 11/24/20 Target upgrade, Microsoft initiation among today's top calls on Wall Street 02/09/21 42nd Annual Aerospace/Defense & Industrials Virtual Conference GE General Electric / + 01/26/21 Early notable gainers among liquid option names on January 26th 01/06/21 General Electric call volume above normal and directionally bullish 12/23/20 Notable open interest changes for December 23rd 12/22/20 General Electric call volume above normal and directionally bullish

Recommendations	Nasdaq price target raised to $160 from $155 at Barclays » 06:38 01/28/21 01/28 06:38 01/28/21 06:38 NDAQ Nasdaq $141.42 / +0.25 (+0.18%) Barclays analyst Jeremy… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options NDAQ Nasdaq $141.42 / +0.25 (+0.18%) 01/27/21 Nasdaq sees 2021 non-GAAP tax rate 25%-27% 01/27/21 Nasdaq expects closing of Verafin acquisition in 1Q21 01/22/21 Nasdaq appoints Jeremy Skule Chief Strategy Officer 01/14/21 Nasdaq says trading halted in Generations Bancorp NY, Inc. NDAQ Nasdaq $141.42 / +0.25 (+0.18%) 01/19/21 Nasdaq upgraded to Buy at UBS on robust volume and organic growth trends 01/19/21 UBS Nasdaq upgraded to Buy from Neutral at UBS 01/13/21 Deutsche Bank Nasdaq price target raised to $163 from $159 at Deutsche Bank 01/12/21 Barclays Nasdaq price target raised to $155 from $147 at Barclays NDAQ Nasdaq $141.42 / +0.25 (+0.18%) 01/27/21 Nasdaq reports Q4 adjusted EPS $1.60, consensus $1.45 10/21/20 Nasdaq reports Q3 adj. EPS $1.58, consensus $1.45 NDAQ Nasdaq $141.42 / +0.25 (+0.18%) 09/29/20 Wall Street data pricing new target for Trump antitrust cop, Bloomberg says 09/29/20 DOJ's Delrahim 'paying close attention' to exchange data pricing, Bloomberg says 09/23/20 Nasdaq, CME plan to launch water futures contract this year, WSJ reports 08/20/20 Airbnb confidentially files paperwork for IPO, WSJ reports NDAQ Nasdaq $141.42 / +0.25 (+0.18%) 11/19/20 Fly Intel: Wall Street's top stories for Thursday 11/19/20 Morgan Stanley sees needed AML fix potentially slowing Square's Cash App growth 11/19/20 Fly Intel: Wall Street's top stories at midday 11/19/20 Fly Intel: Pre-market Movers 02/11/21 Technology & Internet Virtual Conference 02/02/21 Adena T.Friedman NDAQ Nasdaq $141.42 / +0.25 (+0.18%) 12/07/20 Early notable gainers among liquid option names on December 7th
Earnings	McCormick sees FY21 adjusted EPS $2.91-$2.96, consensus $2.96 » 06:38 01/28/21 01/28 06:38 01/28/21 06:38 MKC McCormick $94.08 / -2.01 (-2.09%) Sees FY21 revenue up… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options MKC McCormick $94.08 / -2.01 (-2.09%) 12/30/20 McCormick acquires FONA International for $710M in cash 11/30/20 L Catterton completes sale of Cholula to McCormick for $800M 11/25/20 McCormick recommends stockholder reject mini-tender offer by TRC Capital 11/24/20 McCormick to acquire Cholula parent company from L Catterton for $800M in cash MKC McCormick $94.08 / -2.01 (-2.09%) 11/24/20 Stifel Stifel sees McCormick's acquisition of Cholula brand as 'strategic' 09/24/20 Argus McCormick initiated with a Buy at Argus 07/15/20 Credit Suisse McCormick price target raised to $200 from $187 at Credit Suisse 06/26/20 Deutsche Bank McCormick price target raised to $182 from $156 at Deutsche Bank MKC McCormick $94.08 / -2.01 (-2.09%) 06:35 Today McCormick reports Q4 adjusted EPS 79c, consensus 89c 01/27/21 Notable companies reporting before tomorrow's open 01/27/21 Notable companies reporting before tomorrow's open 11/24/20 McCormick expects Cholula acquisition to be accretive to adj. EPS in 2021 MKC McCormick $94.08 / -2.01 (-2.09%) 12/30/20 Fly Intel: Pre-market Movers 11/24/20 Fly Intel: Wall Street's top stories for Tuesday 09/29/20 Fly Intel: Pre-market Movers 08:00 Today McCormick - MKC MKC McCormick $94.08 / -2.01 (-2.09%) 12/08/20 Largest borrow rate increases among liquid names
Hot Stocks	Northrop Grumman sees FY21 adjusted free cash flow ~$3B-$3.3B » 06:38 01/28/21 01/28 06:38 01/28/21 06:38 NOC Northrop Grumman $292.98 / -0.03 (-0.01%) Sees FY21 operating cash… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events NOC Northrop Grumman $292.98 / -0.03 (-0.01%) 06:36 Today Northrop Grumman reports backlog of $81B 06:34 Today Northrop Grumman announces $3B in additional share repurchases 01/26/21 Northrop Grumman awarded $3.6B ID/IQ BACN pact from U.S. Air Force 01/22/21 Northrop Grumman awarded $155.03M Missile Defense Agency prototype award NOC Northrop Grumman $292.98 / -0.03 (-0.01%) 01/07/21 Baird Northrop Grumman downgraded to Neutral from Outperform at Baird 12/09/20 Noble Capital Kratos Defense price target raised to $26 from $23 at Noble Capital 11/03/20 Morgan Stanley Morgan Stanley sees attractive buying opportunity in Defense stocks 10/13/20 Credit Suisse Northrop Grumman price target lowered to $390 from $400 at Credit Suisse NOC Northrop Grumman $292.98 / -0.03 (-0.01%) 06:36 Today Northrop Grumman sees FY21 adjusted EPS $23.15-$23.65, consensus $24.19 06:33 Today Northrop Grumman reports Q4 adjusted EPS $6.59, consensus $5.77 10/22/20 Northrop Grumman sees FY21 revenue in low-to-mid $37B range, consensus $37.45B 10/22/20 Northrop Grumman raises FY20 adj. EPS view to $22.25-$22.65 from $22.00-$22.40 NOC Northrop Grumman $292.98 / -0.03 (-0.01%) 01/02/21 Congress overturns Trump veto on Defense bill, NPR reports 10/28/20 Northrop Grumman weighs sale of technology services unit, Bloomberg says 10/28/20 Northrop Grumman weighs sale of technology services unit, Bloomberg says NOC Northrop Grumman $292.98 / -0.03 (-0.01%) 01/02/21 Week in review: How Trump's policies moved stocks 12/26/20 Week in review: How Trump's policies moved stocks 12/19/20 Week in review: How Trump's policies moved stocks 12/08/20 Fly Intel: Wall Street's top stories for Tuesday 02/09/21 42nd Annual Aerospace/Defense & Industrials Virtual Conference 09:00 Today Northrop Grumman - NOC
Hot Stocks	Northrop Grumman reports backlog of $81B 06:36 01/28/21 01/28 06:36 01/28/21 06:36 NOC Northrop Grumman $292.98 / -0.03 (-0.01%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events NOC Northrop Grumman $292.98 / -0.03 (-0.01%) 06:34 Today Northrop Grumman announces $3B in additional share repurchases 01/26/21 Northrop Grumman awarded $3.6B ID/IQ BACN pact from U.S. Air Force 01/22/21 Northrop Grumman awarded $155.03M Missile Defense Agency prototype award 01/21/21 Northrop Grumman awarded $3.6B Air Force contract for BACN operations NOC Northrop Grumman $292.98 / -0.03 (-0.01%) 01/07/21 Baird Northrop Grumman downgraded to Neutral from Outperform at Baird 12/09/20 Noble Capital Kratos Defense price target raised to $26 from $23 at Noble Capital 11/03/20 Morgan Stanley Morgan Stanley sees attractive buying opportunity in Defense stocks 10/13/20 Credit Suisse Northrop Grumman price target lowered to $390 from $400 at Credit Suisse NOC Northrop Grumman $292.98 / -0.03 (-0.01%) 06:36 Today Northrop Grumman sees FY21 adjusted EPS $23.15-$23.65, consensus $24.19 06:33 Today Northrop Grumman reports Q4 adjusted EPS $6.59, consensus $5.77 10/22/20 Northrop Grumman sees FY21 revenue in low-to-mid $37B range, consensus $37.45B 10/22/20 Northrop Grumman raises FY20 adj. EPS view to $22.25-$22.65 from $22.00-$22.40 NOC Northrop Grumman $292.98 / -0.03 (-0.01%) 01/02/21 Congress overturns Trump veto on Defense bill, NPR reports 10/28/20 Northrop Grumman weighs sale of technology services unit, Bloomberg says 10/28/20 Northrop Grumman weighs sale of technology services unit, Bloomberg says NOC Northrop Grumman $292.98 / -0.03 (-0.01%) 01/02/21 Week in review: How Trump's policies moved stocks 12/26/20 Week in review: How Trump's policies moved stocks 12/19/20 Week in review: How Trump's policies moved stocks 12/08/20 Fly Intel: Wall Street's top stories for Tuesday 02/09/21 42nd Annual Aerospace/Defense & Industrials Virtual Conference 09:00 Today Northrop Grumman - NOC
Earnings	Northrop Grumman sees FY21 adjusted EPS $23.15-$23.65, consensus $24.19 » 06:36 01/28/21 01/28 06:36 01/28/21 06:36 NOC Northrop Grumman $292.98 / -0.03 (-0.01%) Lowers FY21 revenue view… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events NOC Northrop Grumman $292.98 / -0.03 (-0.01%) 06:34 Today Northrop Grumman announces $3B in additional share repurchases 01/26/21 Northrop Grumman awarded $3.6B ID/IQ BACN pact from U.S. Air Force 01/22/21 Northrop Grumman awarded $155.03M Missile Defense Agency prototype award 01/21/21 Northrop Grumman awarded $3.6B Air Force contract for BACN operations NOC Northrop Grumman $292.98 / -0.03 (-0.01%) 01/07/21 Baird Northrop Grumman downgraded to Neutral from Outperform at Baird 12/09/20 Noble Capital Kratos Defense price target raised to $26 from $23 at Noble Capital 11/03/20 Morgan Stanley Morgan Stanley sees attractive buying opportunity in Defense stocks 10/13/20 Credit Suisse Northrop Grumman price target lowered to $390 from $400 at Credit Suisse NOC Northrop Grumman $292.98 / -0.03 (-0.01%) 06:33 Today Northrop Grumman reports Q4 adjusted EPS $6.59, consensus $5.77 10/22/20 Northrop Grumman sees FY21 revenue in low-to-mid $37B range, consensus $37.45B 10/22/20 Northrop Grumman raises FY20 adj. EPS view to $22.25-$22.65 from $22.00-$22.40 10/22/20 Northrop Grumman reports Q3 EPS $5.89, consensus $5.64 NOC Northrop Grumman $292.98 / -0.03 (-0.01%) 01/02/21 Congress overturns Trump veto on Defense bill, NPR reports 10/28/20 Northrop Grumman weighs sale of technology services unit, Bloomberg says 10/28/20 Northrop Grumman weighs sale of technology services unit, Bloomberg says NOC Northrop Grumman $292.98 / -0.03 (-0.01%) 01/02/21 Week in review: How Trump's policies moved stocks 12/26/20 Week in review: How Trump's policies moved stocks 12/19/20 Week in review: How Trump's policies moved stocks 12/08/20 Fly Intel: Wall Street's top stories for Tuesday 02/09/21 42nd Annual Aerospace/Defense & Industrials Virtual Conference 09:00 Today Northrop Grumman - NOC

Events

Earnings calls, analyst events, roadshows and more

MMYT
Today at 07:30

MakeMyTrip - MMYT Conference Calls
DHR
Today at 08:00

Danaher - DHR Conference Calls
DOW
Today at 08:00

Dow Inc. - DOW Conference Calls
FLWS
Today at 08:00

1-800-Flowers.com - FLWS Conference Calls
SWK
Today at 08:00

Stanley Black & Decker - SWK Conference Calls
ABMD
Today at 08:00

Abiomed - ABMD Conference Calls
RCI
Today at 08:00

Rogers Communications - RCI Conference Calls
MIXT
Today at 08:00

MiX Telematics - MIXT Conference Calls
MKC
Today at 08:00

McCormick - MKC Conference Calls
WHR
Today at 08:00

Whirlpool - WHR Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	EZGO X EZGO EZGO Technologies IPO Managers: Priced at: $4.00 2.8M Shares CRKN X CRKN Crown Electrokinetics Secondary Managers: Roth Capital, National Securities, Colliers Priced at: $4.50 4.15M Shares LPCN X LPCN Lipocine Spot Secondary Managers: Raymond James Priced at: $1.75 14.3M Shares SEEL X SEEL Seelos Therapeutics Spot Secondary Managers: BTIG Priced at: $2.05 15.244M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	SCPS X SCPS Scopus BioPharma IPO Managers: Benchmark, Joseph Gunnar Priced at: $9.00 1M Shares SHLS X SHLS Shoals Technologies IPO Managers: Goldman Sachs, JPMorgan, Guggenheim, UBS, Morgan Stanley, Barclays & Credit Suisse, Cowen, Oppenheimer Priced at: $25.00 77M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TIRX X TIRX Tian Ruixiang IPO Managers: Network 1 Financial Priced at: $4.00 3M Shares GRBK X GRBK Green Brick Secondary Managers: Barclays & Goldman Sachs Priced at: $20.95 6M Shares CBIO X CBIO Catalyst Biosciences Spot Secondary Managers: Piper Sandler, Raymond James Priced at: $5.75 8.7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DZSI X DZSI DZS Spot Secondary Managers: Stifel, Needham & B. Riley Securities Priced at: $14.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLUG X PLUG Plug Power Spot Secondary Managers: Morgan Stanley Priced at: $65.00 28M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PSNL X PSNL Personalis Spot Secondary Managers: Morgan Stanley, BofA, Citi & Cowen Priced at: $38.00 3.95M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial QUMU X QUMU Qumu Spot Secondary Managers: Craig-Hallum Priced at: $6.75 3.225M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	AGFY X AGFY Agrify IPO Managers: Maxim & Roth Capital Priced at: $10.00 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial OCDX X OCDX Ortho Clinical IPO Managers: JPMorgan, BofA, Goldman Sachs, Barclays & Morgan Stanley, Citi, Credit Suisse, UBS, Evercore ISI, Piper Sandler, ING Bank, Macquarie, Nomura, TCG Capital Markets, Drexel Hamilton, H.C. Wainwright, Ramirez, Seibert Williams Priced at: $17.00 76M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VINP X VINP Vinci Partners Investments IPO Managers: JPMorgan, Goldman Sachs & BTG Pactual, Itau BBA, BofA, Credit Suisse, UBS Priced at: $18.00 13.873M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial XM X XM Qualtrics IPO Managers: Morgan Stanley & JPMorgan, BofA, Barclays, Deutsche Bank, Goldman Sachs, HSBC, Citi, BMO Capital, Truist, Canaccord, Evercore ISI, JPMorgan, Oppenheimer, Piper Sandler, Raymond James, William Blair, Loop Capital, RMRZ, SEEL Priced at: $30.00 50.4M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ZIM X ZIM ZIM Integrated IPO Managers: Citi, Goldman Sachs & Barclays, Jefferies, Clarksons Platou Priced at: $15.00 14.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASO X ASO Academy Sports Secondary Managers: Credit Suisse, JPMorgan, KKR & BofA Priced at: $21.50 12M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CVAC X CVAC CureVac Secondary Managers: BofA, Jefferies & Evercore ISI, UBS, Guggenheim, Berenberg, Kempen & Co., Priced at: $90.00 5M Shares SEER X SEER Seer Secondary Managers: JPMorgan, Morgan Stanley, BofA & Cowen Priced at: $67.00 3.75M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SRGA X SRGA Surgalign Secondary Managers: Piper Sandler, Cantor Fitzgerald & BTIG, Craig-Hallum, Lake Street Priced at: $1.50 25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

Mon	ERF X ERF Enerplus Spot Secondary Managers: RBC Capital & BMO Capital $3.37 28.75M Shares
Tues	No deals
Wed	SGRY X SGRY Surgery Partners Secondary Managers: JPMorgan & Jefferies, Barclays, KKR, Macquarie $31.30 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AGTC X AGTC Applied Genetic Spot Secondary Managers: Stifel, Wells Fargo & MTS Health Partners $4.45 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PWFL X PWFL PowerFleet Spot Secondary Managers: Canaccord $8.01
Thurs	HMPT X HMPT Home Point Capital IPO Managers: Goldman Sachs, Wells Fargo, Morgan Stanley & UBS, Credit Suisse, JPMorgan, BofA, JMP Securities, Piper Sandler, Seelaus, SPC Capital, Wedbush, Zelman $19.00-21.00 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SEGR X SEGR Southeastern Grocers IPO Managers: BofA & Goldman Sachs, Deutsche Bank, BMO Capital, Truist, Wells Fargo $14.00-16.00 8.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TRIN X TRIN Trinity Capital IPO Managers: Keefe Bruyette, Wells Fargo & UBS, Janney Montgomery Scott, B. Riley Securities, Ladenburg, Compass Point $13.50-15.50 7.55M Shares CALT X CALT Calliditas Therapeutics Secondary Managers: Citi, Jefferies & Stifel, Kempen & Co.,, LifeSci Capital, Carnegie $31.20 4.5M Shares DCT X DCT Duck Creek Technologies Secondary Managers: Goldman Sachs, JPMorgan & BofA $52.85 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Navios Acquisition falls -10.6%

TODAY'S FREE FLY STORIES

Get Full Fly Access